Lowenstein Reps BASF In Deal For Biotech Co. Verenium

Law360, New York (September 20, 2013, 4:30 PM ET) -- Chemical company BASF Corp. will acquire industrial biotechnology company Verenium Corp., which serves the global food and fuel industries, for about $4 per share, the companies said Friday.

Verenium has about 12.8 million shares outstanding, which would value the deal at about $51 million. The deal is expected to close in the fourth quarter of 2013. The acquisition will bolster BASF’s role in the efficient enzyme space, according to a statement issued by BASF.

“Combining Verenium’s scientific and technological excellence with BASF’s enzyme activities and its...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers